Simplex Trading’s Juniper Pharmaceuticals JNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-5
Closed -$1K – 8267
2018
Q1
$1K Buy
+5
New +$42 ﹤0.01% 5970
2016
Q4
– Sell
-29
Closed -$4K – 6982
2016
Q3
$4K Sell
29
-73
-72% -$483 ﹤0.01% 4587
2016
Q2
$12K Sell
102
-169
-62% -$1.19K ﹤0.01% 3467
2016
Q1
$35K Buy
+271
New +$1.99K ﹤0.01% 2298
2015
Q4
– Sell
-40
Closed -$11K – 6579
2015
Q3
$11K Buy
+40
New +$442 ﹤0.01% 3384

Simplex Trading's JNP Position: Q3 2018 in Review

Simplex Trading sold out of Juniper Pharmaceuticals (JNP) in Q3 2018, closing a stake of 15,474 shares — an estimated $134K sold.

Simplex Trading first reported a position in JNP in Q2 2015 and held it in 9 quarters. The position peaked at $134K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Simplex Trading reported no remaining Juniper Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 15,474 Juniper Pharmaceuticals shares in Q3 2018, an estimated $134K.
  • Simplex Trading first reported a position in Juniper Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • Simplex Trading's Juniper Pharmaceuticals position peaked at $134K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.